Evaluation of Analgesia With EMLA and Glucose Oral Solution

Condition(s) targeted: Pain

Intervention: EMLA (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Federal University of Minas Gerais

Official(s) and/or principal investigator(s):
Yerkes Pereira Silva, PhD, Principal Investigator, Affiliation: Federal University of Minas gerai

In this randomized controlled study the investigators intended to compare analgesic effects of EMLA and/or oral glucose in 60 preterm neonate during arterial function and PICC installation.

Official title: Evaluation of Analgesia With the Use of Eutectic Mixture of Local Anesthetics (Lidocaine and Prilocaine) and Oral Solution of Glucose to 25% in Preterm Neonates During Arterial Puncture and / or the Installation of Percutaneous Catheter

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Primary outcome: Compare analgesic efficacy of EMLA versus oral glucose

Secondary outcome: Evaluate analgesic synergism of EMLA versus oral glucose

Detailed description: It is a randomised controlled clinical trial, double blinded, with the purpose to compare the use of eutectic mixture of local anesthetics (lidocaine and prilocaine) and/or the oral solution of glucose 25% in the prevention and treatment of pain in preterm neonates with gestational between 28-37 weeks old. The pain evaluation will be done using NIPS scale, and also physiologic variables (HR, MAP, oxygen saturation level and crie) during two painful procedures performed in the neonatal intensive care units: arterial puncture (n=30) and peripherally inserted central catheters (n=30). All procedures will have clinical indication and will not be implemented by the researcher. The newborns will be randomized into three groups: A (EMLA and glucose; n=20),B (EMLA AND placebo; n=20) and C (anesthetic cream placebo and oral glucose; n=20). All newborns will be subjected to some kind of therapeutic intervention, the objective of this study is validate the application of control measures and treatment of pain for these two procedures that cause mild and moderate pain.

Minimum age: N/A. Maximum age: 7 Days. Gender(s): Both.

Criteria:

Inclusion Criteria: 1. Gestational age greater than or equal to 28 weeks and less than 37 weeks 2. Admission in the neonatal intensive care unit of the hospital Julia Kubtischek 3. Clinical indication of collection of blood through arterial puncture or peripherally inserted central catheter 4. Neonate in the first week of life (first to seventh day of life); 5. Informed consent have to be obtained by parents or guardians. Exclusion Criteria: 1. Newborn with broken skin at cream application site; 2. Use of sedation or analgesia in the last 72 hours; 3. Diagnosis of necrotizing enterocolitis; 4. Anemia 5. Metabolic acidosis 6. Methaemoglobinaemia 7. Treatment with agents to induce methemoglobinemia 8. Mechanical ventilation in patients using opioids 9. Clinical diagnosis of neuromuscular dysfunction 10. Any contraindication to suction 11. Urgent procedures

Department of Neonatology of Julia Kubitschek Hospital, Belo Horizonte, Minas Gerais, Brazil

Related publications:

Lehr VT, Taddio A. Topical anesthesia in neonates: clinical practices and practical considerations. Semin Perinatol. 2007 Oct;31(5):323-9. Review.

Taddio A, Ohlsson A, Einarson TR, Stevens B, Koren G. A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates. Pediatrics. 1998 Feb;101(2):E1.

Deshmukh LS, Udani RH. Analgesic effect of oral glucose in preterm infants during venipuncture--a double-blind, randomized, controlled trial. J Trop Pediatr. 2002 Jun;48(3):138-41.

Starting date: November 2008
Last updated: July 24, 2014